After being fired, I became the light of medicine

Chapter 56 Giving out red envelopes

As an innovative drug that has just been launched on the market, both doctors and patients are still in the exploratory stage about "ITG human myelopoietin".

As more and more patients received "ITG" injection treatment in the following days, the complete treatment plan and cost of the first version of "ITG eukogenizer" were summarized.

For patients with common aplastic anemia, it is first recommended to undergo eight weeks of treatment with a total of eight injections;

After the eighth week, do a complete blood test and blood cell smear. If all blood test results are normal, then a bone marrow puncture can be performed directly to confirm whether the disease is cured.

If the blood picture is still abnormal, then two more injections will be given, and bone marrow puncture will be performed after ten injections.

The final cost of this set of treatments will not exceed 3 yuan. If you are lucky, eight injections may only cost 2.5 yuan!

For patients with super severe aplastic anemia, twelve injections are also given first, followed by a routine blood test, and a bone marrow puncture is performed if no problems are found.

The cost of this set of fees is not high. With the examination fee and medical treatment fees, the total cost is exactly 3.5 yuan!

but.

This set of plans is just a package provided by Chengdu Third People's Hospital. Hospitals such as West China Hospital and Ruijin Hospital also have their own different plans and prices.

So in the past few days, patients with aplastic anemia have been sharing treatment plans from well-known hospitals across the country in patient groups, forums, etc., comparing prices, etc.

finally,
Chengdu Third People's Hospital has become the first choice for the vast majority of patients with aplastic anemia due to its rich experience and reputation. Many patients from other places even fly thousands of miles here for hospitalization!

For a time, Chengdu Third People's Hospital absorbed the largest number of patients with aplastic anemia, and the department's influence skyrocketed.

Dean Zhou was so happy that he couldn't stop smiling. Faced with the surge in outpatient and inpatient numbers, he hurriedly added two more outpatient doctors to the outpatient center, and the inpatient department also urgently added more than a dozen beds.

of course,

As we all know, the Department of Hematology is not just about "Aplastic Anemia".
Looking at the patients with aplastic anemia in the outpatient clinic laughing and happily receiving treatment, those patients with leukemia and Henoch-Schönlein purpura felt very uncomfortable.

Jealous? A little bit.

Are you envious? Of course.

You know, more than a year ago, all patients with aplastic anemia needed long-term blood transfusions and plate transfusions like them, and also needed to take medicines for life like them, but what about now?
Tsingshan Pharmaceutical saved them.

Thinking about it, all the blood patients felt extremely sad.

“Aplastic anemia patients can be saved by Qingshan Pharmaceutical, but who can save themselves?”

"Is it still Qingshan Pharmaceutical?"

……

No one could hear their cries in their hearts. On the other hand, with the successful launch of "ITG Human Myelopoietin", the sales amount of the first batch was also calculated.

This time, before the "ITG hematology factor" was officially put on sale, it received purchase orders from the top 30 hematology hospitals in the country. In addition, the unit price of "ITG" was much higher than that of "Qingshan Afa".
Qingshan Pharmaceutical now has a terrifying amount of liquid funds in its account!
"Zhang Yang, a total of 32 hospitals purchased our 'ITG Genotropin' in the first batch, and a total of 30000 injections were sold, with sales reaching 8400 million yuan!"

"Even if they only paid 50% of the fees as agreed, combined with the liquidity in the previous account, our current account liquidity has reached 8700 million yuan!"

8700 million!
Zhang Yang finally smiled and felt a lot more relaxed.

What is important is not that so much money has been made, but that Qingshan Pharmaceutical finally has stable, continuous and profitable income!
Next, the profits generated by "Qingshan Afa" and "ITG" every year will be enough to support the development of Qingshan Pharmaceutical for a long time!

but,

In his excitement, he quickly thought of something, and immediately picked up the phone and called the financial director in charge of finance - Lao Qian, Qian Tu.

Qian Tu is in his forties and was one of the first employees recruited when Qingshan Pharmaceutical was first established. He previously worked in a private enterprise and has quite a bit of work experience.

After receiving Zhang Yang's call, Qian Tu didn't dare to neglect it and rushed over with a pile of financial report documents in his hand. "Mr. Zhang, what financial situation do you want to ask me about? Is it the sales profit or the current account revenue?"

Zhang Yang was stunned for a moment, then smiled and shook his head:
"Neither. I asked you to come here today because I am going to give red envelopes to everyone in the company!"

"Red envelope?" Qian Tu was also stunned.

"Yes."

Zhang Yang nodded:
"The successful launch of the company's 'ITG synergist' is a good start."

"Everyone has been busy for this matter for the past six months. Giving out a red envelope can be considered a project reward."

"Not much. All drug developers will receive a bonus of 30,000 yuan, and other office staff will receive 20,000 yuan, including you."

Qian Tu suddenly became excited.
He could understand that drug developers received bonuses, but he didn’t expect that the clerical staff also received bonuses!

"Thank you, Mr. Zhang, thank you, Mr. Zhang..."

Zhang Yang waved his hand and looked at Ren Xiaomin:
"By the way, Brother Ren, I think the company should also set up an employee cafeteria now."

"We will have more and more employees in the future. It's not good for everyone to eat too much takeout every day. It would be better for the company to pay for an employee cafeteria to provide breakfast, lunch and dinner every day..."

"Also, the company should also provide two cars, so that everyone can drive wherever they go for work, which is more convenient..."

Ren Xiaomin was slightly stunned, then nodded:

"I agree."

"Now that we have managed to develop, we should also provide these employee benefits!"

……

While Zhang Yang was improving employee benefits, on the other side, Fosun Pharma, which had previously cooperated with AkaRx, was holding a high-level high-level meeting.

"Mr. Guo, I have already heard some thoughts from AkaRx. They may reduce the price again in the near future, from the current 3000 yuan per box to 1599 yuan per box, the same as Qingshan Afa."

“But even if they continue to lower their prices, I don’t think they can out-compete Tsingshan Pharmaceutical in China.”

The person who spoke was Gao Qiang, a senior executive of Fosun Pharma who had been in contact with AkaRx.

Sitting in the middle of the conference room was Guo Yue, the president and CEO of Fuxing Pharmaceutical.

After hearing Gao Qiang's words, the senior executives present fell silent, and even President Guo Yue couldn't help but frowned.

Everyone knew that Gao Qiang was telling the truth.

A drug can still gain sales by relying on connections when the price and efficacy are similar, but now Qingshan Pharmaceutical not only has "Qingshan Afa", but also has an exclusive drug - "ITG Human Myelopoietin".

Under such circumstances, which hospital dares not to purchase Qingshan Afa?
After more than ten seconds, the silence in the conference room was broken. A senior executive sitting in the middle frowned:

"Then what should we do next?"

“Are we going to just sit there and watch AkaRx go under and our profits go away?”

"We should find a way to save the current situation!"

……

(End of this chapter)